Check-Cap(CHEK) - 2022 Q2 - Quarterly Report

Exhibit 99.1 Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel, June 1, 2022 -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparationfree screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced ...